. 2022 Jun 10;63(8):2024–2036. doi: 10.1111/epi.17304
© 2022 UCB Pharma. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.